General
|
|
|
NEW: Che Arif, Fatin & Hilmi, Mohd Radzi & Kamal, Khairidzan & Ithnin, Mohd
|
Evaluation of 18 artificial tears based on viscosity and pH. Malaysian Journal of Ophthalmology
|
|
|
NEW: Yun-Jung Yang, Won-Young Lee, Young-jin Kim, Yeon-pyo Hong
|
A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome
|
|
|
M Moshirfar, W. B. West Jr. & D. P. Marx
|
Face Mask-Associated Ocular Irritation and Dryness
|
|
|
http://www.mims.co.uk
|
Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients
Potential sensitising agents in eye drops and ointments.
|
|
|
The Ocular Surface Journal
July 2017
Volume 15, Issue 3, p269-650
|
TFOS International Dry Eye WorkShop (DEWS II)
|
|
C Baudouin et al.
|
Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction
|
|
The Ocular Surface Journal
April 2007
Volume 5, Number 2
|
International Dry Eye Workshop (DEWS) 2007
|
|
Pasquale Aragona, Vincenzo Papa, Antonio Micali,
Marcello Santocono, Giovanni Milazzo
|
Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye
|
|
H Mochizuki, M Yamada,
S Hato and T Nishida
|
Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acid
|
|
Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudoin C
Graefes Arch Clin Exp Ophthalmol. 2005 Jun;243(6):531-8. Epub 2004 Dec 17
|
Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis
|
|
Prabhasawat P, Tesavibul N, Kasetsuwan N.
Br. J. Ophthalmol. 2007;91;47-50
|
Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study
|
REMOGEN® Omega
|
|
|
NEW: Fevziye Ondes Yilmaz, et al.
|
Comparison of topical omega-3 fatty acids with topical sodium hyaluronate after corneal crosslinking : Short term results
|
|
Stefano Barabino, et al.
|
The role of systemic and topical fatty acids for dry eye treatment https://doi.org/10.1016/j.preteyeres.2017.05.003
|
VISMED®
|
|
|
NEW: Emine Esra Karaca, Dilay Özek, Özlem Evren Kemer
|
Comparison study of two different topical lubricants on tear meniscus and tear osmolarity in dry eye
|
|
|
Szegedi S, et al.
|
Effect of Single Instillation of Two Hyaluronic Acid-Based Topical Lubricants on Tear Film Thickness in Patients with Dry Eye Syndrome
|
|
|
Baeyens V, Fiorentini R,
Baudouin C, Dorsey F and The French VISMED® Study Group
|
Efficacy and safety of sodium hyaluronate 0.18% (VISMED®) vs sodium chloride 0.9% in patients with bilateral moderate dry eye (Need to register to access full free pdf file)
|
|
|
Ralph Pinheiro, Claudia Panfil, Norbert Schrage, Ralf Michael Dutescu
|
Comparison of the lubricant eyedrops Optive®, Vismed Multi®, and Cationorm® on the corneal healing process in an ex vivo model
|
|
Roger Vogel, R. Stephens Crockett, Neal Oden, Terry W. Laliberte, and Luis Molina, on behalf of the sodium hyaluronate ophthalmic solution study group
|
Demonstration of Efficacy in the Treatment of Dry Eye Disease with 0.18% Sodium Hyaluronate Ophthalmic Solution (Vismed, Rejena)
|
|
C.A. Kirby, and The Vismed Study Group. Invest. Ophthalmol. Vis. Sci. 2009; 50 : E-Abstract 4648-D892. Poster presented at the ARVO, Fort-Lauderdale, 3-7 May 2009
|
Superiority of Vismed® (Sodium Hyaluronate Ophthalmic Solution 0.18%) Compared with its Vehicle in the Treatment of the Signs and Symptoms of Dry Eye Disease
|
|
Baeyens V, Fiorentini R,
Baudouin C, Dorsey F and The French VISMED® Study Group
|
Efficacy and safety of sodium hyaluronate 0.18% (VISMED®) vs sodium chloride 0.9% in patients with bilateral moderate dry eye
|
|
Zeher M, Bereczki Á, Sohajda Z, Márta J, Deák G, Ibnou-Zekri N, Baeyens V, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008
|
A 1-month study of efficacy and safety of 0.18% sodium hyaluronate (Vismed®) vs. 0.3% carbomer and 0.9% saline in patients with bilateral moderate dry eye syndrome
|
|
Johnson ME, Murphy PJ, Boulton M
Graefes Arch Clin Exp Ophthalmol. 2006 Jan;244(1):109-12. Epub 2005 Jun 28.
|
Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye
|
|
Aleo D, Bossy L, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008
|
Considerations on the risk of precipitation of calcium phosphate salts following the use of VISMED® (0.18% sodium hyaluronate) formulation
|
|
Rapisarda A, Battaglia F, Bossy L, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008
|
Efficacy and safety of hypotonic 0.18% sodium hyaluronate solution (VISMED®) in patients with moderate dry eye - A study of the osmolarity of the tear film
|
|
Michael E. Johnson
Paul J. Murphy
Mike Boulton
|
Carbomer and Sodium Hyaluronate Eyedrops for Moderate Dry Eye Treatment
|
VISMED® GEL
|
|
|
NEW: F A Che Arif, K Kamal, M R Hilmi, M H Ithnin
|
Evaluation of 18 artificial tears based on viscosity and pH
|
|
TRB Chemedica
|
VISMED® GEL (Non-Preserved Sodium Hyaluronate eye drops) for the Treatment of Symptoms of Ocular Dryness and Discomfort in Patients with Sjögren's Syndrome
|
|
Clive Peckar
|
The Use of Sodium Hyaluronate Gel 0.3% in the Management of Post-Keratoplasty Patients, Chronic Refractory Dry Eye Patients and other Surface Problems
|
|
Clive Peckar
Article in Eurotimes.
|
Sodium Hyaluronate Based Products. Management of post-LASIK dry eye and other dry eye problems.
|
|
Clive Peckar et al
Eurotimes Roundtable
|
Current Trends in the management of dry eye
|
LASERVIS
|
|
|
Dougherty P.J., Wellish K.L., Maloney R.K. (1994)
|
Excimer Laser Ablation Rate and Corneal Hydration. Am. J of Ophthalm. 118, 169-176
|
|
|
Arshinoff SA, Khoury E.
J Cataract Refract Surg 1997; 23:1221-5.
|
HsS versus a balanced salt solution as a corneal wetting agent during routine cataract extraction and lens implantation
|
|
|
Alio J.L., Belda J.I., Shalaby A.:
2001;108:1246-1260 American Academy of Ophthalmology
|
Correction of Irregular Astigmatism with Excimer Laser Assisted by Sodium Hyaluronate
|
|
|
Vinciguerra P, Camesasca FI.
J Refract Surg 2002; 18(3 Suppl):S371-3.
|
Butterfly laser epithelial keratomileusis for myopia
|
|
|
Lombardo M, Serrao S.(2004):
Excimer Lasers. Journal of Refractive Surgery Vol 20 September/October 2004
|
Smoothing of the ablated porcine anterior corneal surface using Technolas Keratocor 217C and Nidek EC-5000
|
|
|
Vinciguerra P., Camesasca FI, Torres IM
Journal of Refractive Surgery Volume 20 September/October (Suppl) 2004
|
One-year results of custom laser epithalial keratomileusis with the Nidek system
|
|
|
J Cataract Refract Surg 2005;31:39-47 ASCRS & ESCRS
Vinciguerra P., Camesasca F.I., Torres Munoz M.I. (2005):
|
Transition zone design and smoothing in custom laser-assisted subepithelial keratectomy
|
|
|
Vinciguerra P, Munoz MI, Camesasca FI, Grizzi F, Roberts C.
J Cataract Refract Surg. 2005 Jan;31(1):82-7.
|
Long-term follow-up of ultrathin corneas after surface retreatment with phototherapeutickeratectomy.
|
|
|
Lombardo M, De Santo MP, Barberi R, Serrao S.
J Refract Surg. 2005 Sep-Oct;21(5):469-75
|
Roughness of excimer laser ablated corneas with and without smoothing measured with atomic force microscopy
|
VISIOL ®
|
|
|
Belda JI, Artola A, Garcia-Manzanares MD, Ferrer C, Haroun HE, Hassanein A, Baeyens V, Munoz G, Aliò JL
J Cataract Refract Surg 2005; 31:1213-1218 © 2005 ASCRS and ESCRS
|
Hyaluronic acid combined with mannitol to improve protection against free-radical endothelial damage: Experimental Model
|
|
|
Miranda M, Bosch-Morell F, Belda JI, García-Manzanares MD, Barcia J, Alió JL, Romero FJ
Ophthalmic Res. 2007;39(5):260-4. Epub 2007 Sep 12.
|
Protective Effect of Viscoelastics against Retina Lipid Peroxidation
|
|
Peckar C, study results presented at the 24th congress of the Asia-Pacific Academy of Ophthalmology (APAO)-Bali, Indonesia, May 17th, 2009
|
New OVDs: Does 2% Sodium Hyaluronate (VISIOL®) have significant advantages over 1% Sodium Hyaluronate to justify its use in Routine Cataract Phacoemulsification?
|